About the role
Career Category
OperationsJob Description
Department: Global Health Economics & Outcomes Research (HEOR)
Job Family: Evidence Synthesis
Job Type: Full-Time
Location: Hyderabad, India
Reports To: Global HEOR Evidence Synthesis Team Lead
Position Summary
The Global HEOR Evidence Synthesis Manager plays a critical role in supporting Amgen’s global market access and health economics strategy through contributing statistical capabilities and methodological leadership for evidence synthesis methodologies (meta-analyses & ITCs). The Evidence Synthesis Manager will conduct different evidence pooling analyses ranging from meta-analyses, network meta-analyses to population-adjusted indirect treatment comparisons (MAICs and STCs) and health-economic analyses facilitating HTA and payer decision-making.
Educational Qualifications
A Bachelor’s, Master's or Doctoral-level degree in applied statistics, biostatistics, mathematics, operations research, engineering, health economics, pharmacy, and related quantitative fields
Required experience/ knowledge
- Years of relevant experience in evidence synthesis and statistical analyses in the pharmaceutical, biotech or consulting setting: +6 years for Master’s degree and +8 years for Bachelor’s degree.
- Hands-on experience in research design and statistical methods, including estimating survival, pooled treatment effects and other methods to estimate treatment effect
- Experience in conducting health economic analyses such as cost-effectiveness/cost-utility (e.g., markov, partitioned survival model), cost minimization, budget impact, and other techniques, as appropriate
- Proficiency with modeling and statistical tools such as Excel, WinBugs, OpenBugs, JAGS, R or Python.
- Familiarity with AI/ML techniques and Bayesian statistics is a plus.
Key Responsibilities
- Design and conduct advanced evidence synthesis and statistical analyses such as Pairwise Meta-Analysis, Surrogate outcome assessment, Survival analysis, External Control Arm (ECA) analysis, Indirect treatment comparison (ITCs), Network Meta-Analysis, Match adjusted indirect treatment analysis (MAIC), Simulated treatment comparison (STC) and Meta-regression
- Design and develop health economic models for products at all stages of development and launch, using cost-effectiveness/cost-utility (e.g., markov, partitioned survival model), cost minimization, budget impact, and other techniques, as appropriate.
- Ensure quality standards are adhered to in all analyses and new methodologies and techniques are adequately assessed and implemented.
- Plan and conduct statistical analyses of clinical trials, RWE and other relevant data sources and develop supporting technical documentation for statistical analyses and economic models.
- Monitor and integrate evolving HTA guidelines, payer requirements, and methodological advancements.
- Create QC checklists and establish robust QC processes across projects
- To proactively mentor and develop members of the team
Skills & Competencies
- Excellent English oral and written communication, with ability to tailor content to different stakeholders.
- Strong quantitative and analytical skills with attention to detail.
- Strong project management and time-management abilities.
- Innovative use of artificial intelligence to boost efficiency.
Organizational Behaviors
- Effective cross-functional collaboration and interpersonal skills.
- Proactive, independent, and detail-oriented approach to problem-solving.
- Comfortable working in a global team across time zones and cultures.
Aplyr's read
Amgen is a biotechnology leader focused on innovative therapeutics in oncology, cardiovascular, and inflammation, attracting professionals in science, engineering, and data analytics.
What's promising
- •Strong focus on cutting-edge biotechnology and human therapeutics.
- •Diverse career opportunities in scientific, engineering, and data roles.
- •Commitment to addressing serious health conditions like cancer and cardiovascular disease.
What to watch
- •Highly competitive industry with constant innovation demands.
- •Regulatory challenges in developing and marketing new therapies.
- •Potential for high-pressure work environment due to ambitious goals.
Why Amgen
- •Pioneering in biologic therapies with a focus on serious diseases.
- •Robust pipeline of innovative drugs in various therapeutic areas.
- •Global presence with a strong emphasis on research and development.
Aplyr’s read is generated by AI from public sources. Was it useful?
About Amgen
Amgen is a leading biotechnology company that discovers, develops, manufactures, and delivers innovative human therapeutics. The company focuses on areas such as oncology, cardiovascular disease, and inflammation.